Pearl Tam
Allergy & Immunology · New York, NYNPI 1649331471
Payments from drug & device makers
Across 159 payments — averaging $46.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Pfizer$899
- GSK$632
- Alk-abello, Inc$610
- Sanofi$375
- ARS Pharmaceuticals Operations, Inc.$300
- plus $2K from 18 others
What the payments were for
- Food & beverage$7,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 62 | $2,558 |
| Pfizer | 22 | $899 |
| GSK | 28 | $632 |
| Alk-abello, Inc | 8 | $610 |
| Sanofi | 4 | $375 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $300 |
| Incyte Corporation | 3 | $287 |
| Regeneron Healthcare Solutions, Inc. | 2 | $217 |
| LEO Pharma Inc. | 3 | $150 |
| Novartis | 3 | $144 |
| Optinose US, Inc. | 2 | $134 |
| Journey Medical Corporation | 1 | $125 |
| Bristol Myers Squibb | 1 | $122 |
| Bayer | 1 | $119 |
| Gilead | 1 | $116 |
| Boehringer Ingelheim | 5 | $116 |
| Insmed, Inc. | 1 | $114 |
| Aclaris Therapeutics, Inc. | 1 | $104 |
| Dermavant Sciences, Inc. | 2 | $93 |
| UCB, Inc. | 2 | $66 |
| E.r. Squibb & Sons, L.L.C. | 1 | $62 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $41 |
| Almirall LLC | 1 | $20 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,414 in reported general payments places this provider in the 65th percentile of 320 allergy & immunology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $25,475 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,687 |
| Atrovent HfaIpratropium Bromide | 11 | $5,068 |
| Azelastine Hcl | 122 | $2,559 |
| Mupirocin | 102 | $1,155 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $939 |
| Levocetirizine Dihydrochloride | 225 | $907 |
| Fluticasone Propionate | 102 | $841 |
| CiclopiroxCiclopirox Olamine | 19 | $786 |
| Mometasone Furoate | 22 | $691 |
| Famotidine | 57 | $345 |
| Triamcinolone Acetonide | 37 | $285 |
| Montelukast Sodium | 45 | $193 |
| Chlorhexidine Gluconate | 48 | $184 |
| ErythromycinErythromycin Base | 16 | $170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $632 | $25,47540 claims |
| AstraZenecaBreztri Aerosphere | $2,558 | $10,68717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in New York
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$980K
- Paula BusseNew York$821K
- Richard InselNew York$269K
- Joyce YuNew York$209K
- Arthur LubitzNew York$196K
- Purvi ParikhNew York$196K
- Charlotte Cunningham-RundlesNew York$180K
- Ama AlexisNew York$120K
- Zoya TreysterNew York$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.